Literature DB >> 15481946

Strategy for profiling and structure elucidation of mucin-type oligosaccharides by mass spectrometry.

Jinhua Zhang1, Leann L Lindsay, Jerry L Hedrick, Carlito B Lebrilla.   

Abstract

A strategy combining accurate mass determination, tandem mass spectrometry, structure homology, and exoglycosidases is described that allows the structural characterization of mucin-type O-linked oligosaccharides. The method is used to profile with quantitation the O-linked oligosaccharide (both neutral and anionic) components of the only diploid Xenopus frog, Xenopus tropicalis. Collision-induced dissociation was used to determine connectivity, to identify previously characterized oligosaccharides, and to determine the presence of structural motifs in unknown oligosaccharides. Exoglycosidase digestion was used to identify the individual residues along with the linkages. The enzymes were also used to cleave larger oligosaccharides to smaller units that are similar to previously elucidated components. By using CID, isomeric structures were compared to determine whether they were identical. In this way, the exoglycosidases were more effectively used, and their use was minimized. A total of 35 oligosaccharides including neutral, sialylated, and sulfated were characterized in this way. The relative abundances of all components were also determined based on HPLC.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15481946     DOI: 10.1021/ac049666s

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


  17 in total

1.  Tunable transition metal-ligand complexation for enhanced elucidation of flavonoid diglycosides by electrospray ionization mass spectrometry.

Authors:  Michael Pikulski; Apolonio Aguilar; Jennifer S Brodbelt
Journal:  J Am Soc Mass Spectrom       Date:  2006-11-16       Impact factor: 3.109

Review 2.  New hyphenated methodologies in high-sensitivity glycoprotein analysis.

Authors:  Milos V Novotny; Yehia Mechref
Journal:  J Sep Sci       Date:  2005-10       Impact factor: 3.645

3.  An infant-associated bacterial commensal utilizes breast milk sialyloligosaccharides.

Authors:  David A Sela; Yanhong Li; Larry Lerno; Shuai Wu; Angela M Marcobal; J Bruce German; Xi Chen; Carlito B Lebrilla; David A Mills
Journal:  J Biol Chem       Date:  2011-02-02       Impact factor: 5.157

4.  Characterization of novel O-glycans isolated from tear and saliva of ocular rosacea patients.

Authors:  Sureyya Ozcan; Hyun Joo An; Ana C Vieira; Gun Wook Park; Jae Han Kim; Mark J Mannis; Carlito B Lebrilla
Journal:  J Proteome Res       Date:  2013-02-06       Impact factor: 4.466

Review 5.  Mass spectrometry and glycomics.

Authors:  Joseph Zaia
Journal:  OMICS       Date:  2010-08

6.  Development of an annotated library of neutral human milk oligosaccharides.

Authors:  Shuai Wu; Nannan Tao; J Bruce German; Rudolf Grimm; Carlito B Lebrilla
Journal:  J Proteome Res       Date:  2010-08-06       Impact factor: 4.466

7.  Structure determination by MALDI-IRMPD mass spectrometry and exoglycosidase digestions of O-linked oligosaccharides from Xenopus borealis egg jelly.

Authors:  Bensheng Li; Scott C Russell; Jinhua Zhang; Jerry L Hedrick; Carlito B Lebrilla
Journal:  Glycobiology       Date:  2011-01-09       Impact factor: 4.313

8.  Annotation and structural analysis of sialylated human milk oligosaccharides.

Authors:  Shuai Wu; Rudolf Grimm; J Bruce German; Carlito B Lebrilla
Journal:  J Proteome Res       Date:  2011-01-06       Impact factor: 4.466

Review 9.  Analysis of carbohydrates and glycoconjugates by matrix-assisted laser desorption/ionization mass spectrometry: An update for 2003-2004.

Authors:  David J Harvey
Journal:  Mass Spectrom Rev       Date:  2009 Mar-Apr       Impact factor: 10.946

10.  Mass spectrometric profiling of N-linked oligosaccharides and uncommon glycoform in mouse serum with head and neck tumor.

Authors:  Erika Lattová; Sonal Varma; Tedros Bezabeh; Ladislav Petrus; Hélène Perreault
Journal:  J Am Soc Mass Spectrom       Date:  2008-02-14       Impact factor: 3.109

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.